News

Biogen commits $2 billion to expand NC’s RTP campuses amid pharma tariff threat
The drugmaker has invested $10 billion in Wake and Durham counties over the past 30 years. Biogen says that figure will increase.
BioSpace1d
Biogen Commits $2B To Expand US Drug Production Amid Tariff Talk
The biotech is planning to expand antisense oligonucleotide capabilities and infrastructure on campuses that already produce ...
Biogen expanding to keep pace with modernization, artificial intelligence
The Fortune 500 company based in Cambridge, Mass., opened its first campus in the Research Triangle Park in 1995.
Biogen to invest $2 billion in RTP, open new factory in 2025
Biogen Inc. has announced a $2 billion investment to expand its manufacturing capabilities at Research Triangle Park (RTP), ...
StockStory.org on MSN1d
Biogen (BIIB) Stock Trades Down, Here Is Why
Shares of biotech company Biogen (NASDAQ:BIIB) fell 3.1% in the morning session after analysts at Truist downgraded the stock ...
Biogen Bets Big On $2 Billion Expansion To Boost US Drug Manufacturing
Biogen will invest an extra $2 billion to expand its RTP facilities, focusing on AI-driven manufacturing and late-stage ...
Biogen to Highlight Scientific Progress Across Alzheimer’s Disease at the Alzheimer’s Association International Conference 2025
Lecanemab presentations to include long-term Clarity AD data, real-world treatment insights, and a subcutaneous formulation ...
Barchart on MSN4d
Here's What to Expect From Biogen's Next Earnings Report
Valued at a market cap of $18.9 billion, Biogen Inc. (BIIB) is a biotechnology company that discovers, develops, manufactures ...